Back to News
Market Impact: 0.55

Stifel initiates Buy rating on Maple Leaf Foods stock amid earnings recovery

SF
Company FundamentalsAnalyst InsightsCorporate EarningsCorporate Guidance & OutlookConsumer Demand & Retail
Stifel initiates Buy rating on Maple Leaf Foods stock amid earnings recovery

Stifel analysts initiated coverage of Maple Leaf Foods (MFI) with a Buy rating and a Cdn$36.50 price target, citing the company's ongoing earnings recovery and strategic initiatives, including the divestiture of its pork processing operations. The firm's valuation is based on a sum-of-the-parts analysis, incorporating a 10x multiple on the 2026 EBITDA for the Consumer Packaged Goods segment and a 5.5x multiple on Canada Packers EBITDA estimates, highlighting improved market conditions and a streamlined manufacturing footprint.

Analysis

Stifel has initiated coverage on Maple Leaf Foods Inc. (TSX:MFI) with a Buy rating and a Cdn$36.50 price target, signaling confidence in the company's ongoing turnaround. This positive outlook is underpinned by a significant earnings recovery, which Stifel notes bottomed in the first quarter of 2023 when financial leverage peaked at six times trailing twelve months' EBITDA. Maple Leaf Foods is reportedly benefiting from improved market conditions in its pork operations and efficiencies gained from consolidating its manufacturing footprint after substantial capital investments. A key strategic development is management's plan to simplify the corporate structure, notably through the upcoming divestiture of its pork processing operations. Stifel's valuation employs a sum-of-the-parts methodology, applying a 10x multiple to the 2026 EBITDA forecast for Maple Leaf Foods’ Consumer Packaged Goods segment and a 5.5x multiple to its Canada Packers EBITDA estimates, suggesting that the company's established brands and strategic initiatives are well-positioned for future growth by resonating with Canadian consumers.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo